Borderline Personality Disorder Clinical Trial
— ProChildOfficial title:
Preventing Maltreatment and Promoting Mental Health in Children of Mothers With Borderline Personality Disorder - ProChild
NCT number | NCT04169048 |
Other study ID # | RenRos02 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 4, 2020 |
Est. completion date | March 2023 |
The first disorder-specific parenting training program for mothers with Borderline
Personality Disorder (M-BPD) is evaluated in a randomized controlled trial.
The training program is expected to have positive effects on parenting behavior, decrease the
risk of maltreatment of the child, and improve emotion regulation in mothers at post
treatment and at 6-month follow-up compared to a control group (treatment as usual; TAU).
Additionally, disorder-specific aspects of dysfunctional parenting behavior as well as
BPD-specific aspects of child maltreatment are compared to a clinical control group (mothers
with anxiety and/or depression, M-AD/D) and a healthy control group (M-CON).
To assess the differential development of parenting, the risk of maltreatment and emotion
dysregulation in untreated M-BPD are compared to M-CON. The investigators expect the
difference to increase over time, indicating a worsening in BPD parenting.
Status | Recruiting |
Enrollment | 240 |
Est. completion date | March 2023 |
Est. primary completion date | June 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria for mothers with BPD: 1. diagnosed with BPD (assessed via SCID-PD) 2. running or completed therapy for BPD symptoms 3. child between 6 months and 6 years 4. living with child or regular (weekly) contact Exclusion criteria for the mothers with BPD 1. Acute child endangerment 2. maternal acute suicidality 3. maternal psychotic symptoms (assessed via SCID-CV) 4. maternal acute alcohol or drug dependency (assessed via SCID-CV) 5. maternal diagnosed intellectual disability. Inclusion criteria for mothers with depression and/or anxiety disorders: 1. diagnosed with acute affective or anxiety disorder (assessed via SCID-CV) 2. child between 6 months and 6 years 3. living with child or regular (weekly) contact Exclusion criteria for mothers with depression and/or anxiety disorders: 1. Acute child endangerment 2. maternal acute suicidality 3. maternal psychotic symptoms (assessed via SCID-CV) 4. maternal acute alcohol or drug dependency (assessed via SCID-CV) 5. maternal diagnosed intellectual disability 6. lifetime diagnosis of BPD (assessed via SCID-PD) Inclusion criteria for healthy control group: 1. child between 6 months and 6 years 2. living with child or regular (weekly) contact Exclusion criteria for the healthy control group: 1. Acute child endangerment 2. maternal acute suicidality 3. maternal psychotic symptoms (assessed via SCID-CV) 4. maternal acute alcohol or drug dependency (assessed via SCID-CV) 5. maternal diagnosed intellectual disability. 6. lifetime diagnosis of BPD (assessed via SCID-PD) 7. any acute mental disorder (assessed via SCID-CV) 8. current psychotherapy |
Country | Name | City | State |
---|---|---|---|
Germany | Freie Universität Berlin | Berlin |
Lead Sponsor | Collaborator |
---|---|
Freie Universität Berlin | Ruhr University of Bochum, University of Bremen |
Germany,
Buck-Hostkotte, S., Renneberg, B. & Rosenbach, C. (2015). Mütter mit Borderline-Persönlichkeitsstörung. Das Trainingsmanual "Borderline und Mutter sein". Weinheim: Beltz.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Negative intervention outcomes | Questionniare assessing negative intervention outcomes (INEP, Ladwig, Rief, & Nestoriouc, 2014).The INEP measures negative effects of psychotherapy in different areas of life (intrapersonal change, relationships, friendships, family, malpractice, and stigmatization). Range from -3 to +3. Higher values indicating better therapeutic course. | week 12 (after treatment) (intervention group only) | |
Other | client satisfaction | Client Satisfaction Questionnaire (CSQ-8, Attkisson & Zwick, 1982; German ZUF-8; Schmidt, Lamprecht & Wittmann, 1989). CSQ-8 measures client satisfaction with intervention. Range 8-32 with higher values indicating greater satisfaction. | week 12 (after treatment) (intervention group only) | |
Primary | Change in dysfunctional discipline practices | Parenting Scale (Arnold, O'Leary, Wolff & Acker, 1993; german version: Erziehungsfragebogen-Kurzform, EFB-K; Miller, 2001). Questionniare measuring dysfunctional discipline practices in parents. Mean values range between 1-7 with higher values indicating more negative parenting strategies. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in positive and dysfunctional parenting strategies | Alabama Parenting Questionnaire (Frick, 1991; German DEAPQ-EL-GS; Reichle & Franiek, 2007). The questionnaire assesses several parenting strategies with 7 subscales (positive parenting, responsible parenting, parental Involvement, poor monitoring/supervision, inconsistent discipline, corporal punishment, powerful implementation). Range 6-30, with higher values indicating more of the respective parenting strategy | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in child rearing competence | Parenting Sense of Competence Scale (PSOC, Gibeau- Wallston & Wandersman, 1978; German FKE; Miller, 2001). The PSOC measures how parents perceive their child rearing competence. Range 0-96 with higher values indicating higher sense of competence. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in parental stress | Parental Stress Index (PSI, Abidin, 1995; German EBI; Tröster, 2010). The PSI is a dimensional rating of parental stress. Range 48 - 240 with higher values indicating higher stress. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in physical and psychological aggression towards child | Conflict Tactic Scale - Parent Child (CTS-PC; Strauss, 1998). The CTSPC measures the extent to which a parent has carried out specific acts of physical and psychological aggression. Range 0-300 with higher values indicating higher annual frequency | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in physical abuse potential | Child Abuse Potential Inventory (CAPI, Milner, 1986, German EBSK; Deegener et al., 2009). The CAPI measures physical abuse potential with reference to the individual burden and three validity scales: a lie scale, a random response scale, and an inconsistency scale. t-values are calculated considering all scales. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Primary | Change in child neglect | Child Neglect Index (CNI; Trocmé, 1996). The CNI measures child neglect, rated by the diagnostician. Range 0-80 with higher values indicating higher neglect. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) and for the intervention group after each session. | |
Secondary | Change in emotion regulation | Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). Difficulties in emotion regulation are measured with a) awareness and understanding of emotions; (b) acceptance of emotions; (c) the ability to engage in goal-directed behavior, and refrain from impulsive behavior, when experiencing negative emotions; and (d) access to emotion regulation strategies perceived as effective. Range 36 - 180 with higher values indicating more problems in emotion regulation. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Secondary | Change in mental distress | Brief Symptom Inventory (BSI, Derogatis, 1975; German: Franke, 2000). The BSI measures mental distress. Results are displayed via t-values. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) | |
Secondary | Change in borderline specific thoughts and feelings | Questionnaire of Thoughts and Feelings (QTF, Renneberg et al., 2010). The QTF measures borderline specific thoughts and feelings. Range 1-5 with higher values indicating more BPD-specific thoughts and feelings. | day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |